Divestment

Luxendo

Luxendo developed light-sheet microscopy systems.

Responsible partner
News

Key Facts

Sector: Life Sciences
Country: Germany
Fund: LSP 5
Entry: 2015
Exit: 2017

Responsible Partner

Joachim Rothe

Joachim Rothe

Partner

News

January 20, 2026
EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer’s therapy into clinical Phase 2
January 12, 2026
EQT Life Sciences backs Kinaset Therapeutics’ USD103 million Series B to advance inhaled therapeutic for treatment of respiratory diseases
January 12, 2026
EQT Real Estate acquires a portfolio of four high-quality logistics assets in Northern Italy
January 12, 2026
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics

Do You Want to Know More?

We are eager to explore how we can achieve great things together.

Luxendo | EQT Portfolio